Sandia Labs seeks partners for Ebola detection device

Sandia National Laboratories wants to partner with companies to create a fast-acting detection system for Ebola and related viruses.

The lab, managed by a subsidiary of Lockheed Martin Corporation, recently developed a detection device for the bacteria behind anthrax infections. It is the size of a credit card and is a stand-alone system that is ideal for low-resource environments and in the field. It is similar to a pregnancy test, and can be used by individuals with little to no medical or technical knowledge. It also has self-propelled decontamination and sterilization, leaving little risk to the user.

Researchers at the lab believe this technology can be adapted for Ebola viruses and related filoviruses.

Sandia is looking for a partner with experience and expertise in developing bioanalytical devices, specifically ones used to identify pathogens; experience in low-cost manufacturing of these devices; and those with low-resource device experience.

Companies should also be able to afford the funding and be able to present a strategy for the enhancement of this technology.

Partnering companies may sign a Cooperative Research & Development Agreement or a Work for Others agreement with Sandia National Labs.

Interested parties should contact Jason Harper at

Organizations in this Story

Lockheed Martin

Get notified the next time we write about Lockheed Martin!